These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38342251)

  • 21. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in Colorectal Cancer.
    Lei X; Jing J; Zhang M; Guan B; Dong Z; Wang C
    Nutr Cancer; 2021; 73(11-12):2568-2578. PubMed ID: 33153324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pks-positive Escherichia coli in tumor tissue and surrounding normal mucosal tissue of colorectal cancer patients.
    Miyasaka T; Yamada T; Uehara K; Sonoda H; Matsuda A; Shinji S; Ohta R; Kuriyama S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kanaka S; Ohashi R; Yoshida H
    Cancer Sci; 2024 Apr; 115(4):1184-1195. PubMed ID: 38297479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TBX15 and SDHB expression changes in colorectal cancer serve as potential prognostic biomarkers.
    Golozar M; Motlagh AV; Mahdevar M; Peymani M; InanlooRahatloo K; Ghaedi K
    Exp Mol Pathol; 2024 Apr; 136():104890. PubMed ID: 38378070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
    Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated analysis of genes associated with poor prognosis of patients with colorectal cancer liver metastasis.
    Qian Z; Zhang G; Song G; Shi J; Gong L; Mou Y; Han Y
    Oncotarget; 2017 Apr; 8(15):25500-25512. PubMed ID: 28424419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
    Yi W; Xiao E; Ding R; Luo P; Yang Y
    Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of GUCA2A and COL3A1 as prognostic biomarkers in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation.
    Hosseini ST; Nemati F
    Sci Rep; 2023 Oct; 13(1):17086. PubMed ID: 37816854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive transcriptome profiling of Taiwanese colorectal cancer implicates an ethnic basis for pathogenesis.
    Wu SM; Tsai WS; Chiang SF; Lai YH; Ma CP; Wang JH; Lin J; Lu PS; Yang CY; Tan BC; Liu H
    Sci Rep; 2020 Mar; 10(1):4526. PubMed ID: 32161294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable Colorectal Cancer Prognosis.
    Cui C; Zhang R; Gu F; Pei Y; Sun L; Huang Y; Niu G; Li J
    J Immunol Res; 2022; 2022():1336509. PubMed ID: 35664357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer.
    Li R; Zhou R; Wang H; Li W; Pan M; Yao X; Zhan W; Yang S; Xu L; Ding Y; Zhao L
    Cell Death Differ; 2019 Nov; 26(11):2447-2463. PubMed ID: 30850734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
    Chen J; Wang Z; Shen X; Cui X; Guo Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database.
    Wang G; Wang F; Meng Z; Wang N; Zhou C; Zhang J; Zhao L; Wang G; Shan B
    BMC Cancer; 2022 Feb; 22(1):138. PubMed ID: 35114976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
    Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
    Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
    Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
    Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of four novel hub genes as monitoring biomarkers for colorectal cancer.
    Luo D; Yang J; Liu J; Yong X; Wang Z
    Hereditas; 2022 Jan; 159(1):11. PubMed ID: 35093172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 39. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
    Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FJX1 as a candidate diagnostic and prognostic serum biomarker for colorectal cancer.
    Liu L; Huang Y; Li Y; Wang Q; Hao Y; Liu L; Yao X; Yao X; Wei Y; Sun X; Guo Y
    Clin Transl Oncol; 2022 Oct; 24(10):1964-1974. PubMed ID: 35650386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.